HBI-2375

N/A

Report date: 2024/11/14 15:48:41
NME

Base Information

Drug NameHBI-2375
Drug Alias NameHBI-2375
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein interaction domain and motifs inhibitorsWD repeat-containing protein 5 inhibitors
TargetsWD repeat-containing protein 5
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHuya Bioscience International Llc
China Registration ClassN/A

Develop Information

Active CompaniesHuya Bioscience International Llc
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A